4//SEC Filing
TETI NICHOLAS 4
Accession 0001181431-10-049396
CIK 0001371217other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 5:30 PM ET
Size
17.8 KB
Accession
0001181431-10-049396
Insider Transaction Report
Form 4
EnteroMedics IncETRM
TETI NICHOLAS
Director
Transactions
- Purchase
Up Front Warrant
2010-09-30$0.13/sh+10,840$1,355→ 10,840 totalExercise: $2.15→ Common Stock (10,840 underlying) - Purchase
Series A NonVoting Convertible Preferred Stock
2010-09-30$1.72/sh+10,840$18,645→ 10,840 totalFrom: 2010-09-30→ Common Stock (10,840 underlying)
Holdings
- 0
No securities are held
- 4,578
Stock Option (right to buy)
Exercise: $44.77From: 2007-04-27Exp: 2017-04-27→ Common Stock (4,578 underlying) - 12,500
Stock Option (right to buy)
Exercise: $3.24From: 2010-02-10Exp: 2020-02-10→ Common Stock (12,500 underlying) - 1,666
Stock Option (right to buy)
Exercise: $26.41From: 2008-05-06Exp: 2018-05-06→ Common Stock (1,666 underlying) - 25,000
Stock Option (right to buy)
Exercise: $13.80From: 2009-05-28Exp: 2019-05-28→ Common Stock (25,000 underlying)
Footnotes (7)
- [F1]Vests as to 25% on date noted and thereafter in cumulative installments of 1/36th per month.
- [F2]Vests in cumulative installments of 1/36th per month beginning the date shown.
- [F3]25,0000 shares vest immediately and the remaining 50,000 shares vest in cumulative installments of 1/36th per month beginning 3/10/2010.
- [F4]On July 9, 2010, EnteroMedics Inc. effected a 1-for-6 reverse stock split of its issued and outstanding shares of common stock, par value $0.01 per share, resulting in a proportional decrease in the total shares of common stock beneficially owned by the reporting person. All previously reported exercise prices, options grants and similar instruments convertible into common stock were proportionally adjusted to reflect the reverse split.
- [F5]The Series A preferred stock is convertible into EnterMedics common stock on a 1-for-1 basis. Upon the completion of certain financings, as described in the Certificate of Designations, additional conversion warrants may be issued. If the converson warrants are issued by the Company, the reporting person would pay $0.125 per conversion warrant with such warrant price to be paid through an adjustment to the conversion.
- [F6]Not applicable.
- [F7]The later of six months from the date of issuance, or the completion of a financing described in the certificate of designations.
Documents
Issuer
EnteroMedics Inc
CIK 0001371217
Entity typeother
Related Parties
1- filerCIK 0001200882
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 5:30 PM ET
- Size
- 17.8 KB